Cancer that occurs in the cells of a woman's cervix is called cervical cancer. The cervix is the section of the uterus that connects the uterus or uterus to the vagina. Cervical cancer arises when abnormal cells in the cervix grow out of control and invade neighboring tissues, sometimes spreading to other areas of the body. The cervix is a very important organ in the female reproductive system; in a way, it is the passageway for menstrual fluid to prepare the body for a potential pregnancy, and it forms the lower part of the birth canal during childbirth. Most cervical cancers arise from the transformation zone, the area where the columnar glandular cells of the cervical canal meet the squamous cells that line the outer vagina. This creates a point vulnerable to transformation. The most common cause of cervical cancer cases is ongoing infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus that causes the growth or multiplication of the inner cells of the cervix.
Cervical cancer grows slowly and often develops as a precancerous condition, called cervical intraepithelial neoplasia (CIN) or squamous intraepithelial lesion (SIL). Such changes may not always turn into cancer; however, they may become invasive over time if ignored or untreated, resulting in cervical cancer disease. The most common and predominant forms of cervical cancer are squamous cell carcinoma, which arises from the flat, thin cells that line the outer cervix, and adenocarcinoma which develops from mucus-producing glandular cells in the cervical canal. Squamous cell carcinoma accounts for the majority of all cases of cervical cancer, while adenocarcinoma accounts for a smaller share, but its number has been increasing in recent years.
Cervical cancer usually remains symptomless in the early stages, making regular screening crucial for early detection and prevention. If a woman develops symptoms, some of them may be: abnormal vaginal bleeding (for example, after intercourse, between menstrual periods, or after menopause); abnormal vaginal discharge that is generally abnormal (may be watery or thick or sometimes blood-stained); and pelvic pain or pain during sex. If these worse stages of cancer are present, they may be accompanied by other symptoms such as difficulty in urinating, bloody urine, swelling in the legs, and/or back pain indicating involvement of nearby tissues or organs.
The development of cervical carcinoma is primarily associated with persistent infection by high-risk HPV types i.e. HPV-16 and HPV-18 which contribute to the maximum number of cases worldwide. This process involves how the virus integrates into the DNA of cervical cells and causes abnormal growth of these cells, which can eventually develop into cancer. However, it has been noted that most infections with HPV spread widely and are reversed by nature without harming one's health, except when there is a prolonged infection with high-risk types, as this causes gradual cellular changes. Other risk factors for cervical cancer are smoking, which reduces the immune power to keep HPV in the actor stage; AIDS, which mainly deprives a person's immune system of functioning; taking oral contraceptives for a long time; having early sexual intercourse or having sex with multiple partners, which increases the risk of exposure to HPV; and a person's history of sexually transmitted infections.
Cervical cancer is one of the most completely preventable cancers thanks to effective screening programs and its vaccines against a virus called HPV. The Pap smear, or Pap test, is an important processing method in detecting precancerous changes in cervical cells that enable early intervention before the development of invasive cancer. Moreover, in recent years, HPV testing has also become an important tool to identify women at risk of cervical cancer. Vaccination against HPV has proven to be one of the best preventive measures against the infectious types mostly associated with cervical cancer, and this practice is recommended before becoming sexually active, which is mostly in adolescence.
Cervical cancer is one of the most common cancers in women worldwide, especially in low- and middle-income countries, where access to screening and vaccination is very constrained. Improving access to HPV vaccination, further/ongoing improvements in screening programs, and raising public awareness on the importance of preventive early detection will reduce the burden of cervical cancer. However, in low-resource health care settings, cervical cancer remains one of the leading causes of cancer deaths in women; thus, equitable access to preventive measures and treatment is essential.
Depending on the stage affected, the type of cancer, and the overall health of the patient, treatment for cervical cancer will vary. Early stages of cancer may be treated with surgical procedures such as hysterectomy or the more conservative approach of cone biopsy for women who wish to maintain their fertility. In advanced stages, therapy will usually involve radiation and chemotherapy treatment to destroy cancer cells and limit its spread. In cases where cancer will spread to other parts of the body, palliative care may be needed to manage symptoms and improve quality of life.
Cervical cancer research is still focused on the molecular mechanisms of the disease, targeted treatments, and preventive strategies. Pioneering advances in immunotherapy as well as immunotherapy that uses the immune system against cancer, and precision medicine to tailor treatments specific to genetic and molecular profiles hold promise for improved outcomes in cervical cancer survivors. Bringing all these innovative approaches together with current preventive measures will be important in reducing the global burden of cervical cancer and achieving the goal of eliminating it as a public health problem.
Public health interventions on cervical cancer should influence community knowledge, promote vaccination programmes and adopt cost-effective screening practices. Governments, health care organisations and NGOs have been partnering to overcome barriers to care and ensure that all people have access to lifesaving interventions regardless of their socio-economic status. Prevention, early detection and wider access to treatment can contribute significantly to reducing the global burden of cervical cancer and thus improving the health status of millions of women worldwide.
